Repare Therapeutics Inc. financial data

Symbol
RPTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
7171 Frederick Banting, Suite 270, Building 2, Saint Laurent, Quebec, Canada
State of incorporation
Canada (Federal Level)
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 702 % +47.3%
Debt-to-equity 16.5 % -40.1%
Return On Equity -40.9 % -5.86%
Return On Assets -35.1 % -15.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42.5M shares +0.9%
Common Stock, Shares, Outstanding 42.5M shares +0.91%
Entity Public Float 383M USD -15.8%
Common Stock, Value, Issued 487M USD +0.72%
Weighted Average Number of Shares Outstanding, Basic 42.5M shares +0.83%
Weighted Average Number of Shares Outstanding, Diluted 42.5M shares +0.83%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 127M USD -1.18%
General and Administrative Expense 32M USD -3.11%
Operating Income (Loss) -93.7M USD +10.7%
Nonoperating Income (Expense) 11.3M USD -13%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -82.4M USD +10.4%
Income Tax Expense (Benefit) 1.63M USD -70.1%
Net Income (Loss) Attributable to Parent -84M USD +13.7%
Earnings Per Share, Basic -1.99 USD/shares +13.9%
Earnings Per Share, Diluted -2 USD/shares +9.91%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 80.5M USD -25%
Marketable Securities, Current 98.9M USD -30.7%
Assets, Current 200M USD -27.2%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 2.75M USD -41.8%
Operating Lease, Right-of-Use Asset 2.47M USD -36.3%
Other Assets, Noncurrent 179K USD -54.9%
Assets 206M USD -27.9%
Accounts Payable, Current 10.7M USD +95.9%
Employee-related Liabilities, Current 4.99M USD -2.23%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 31.1M USD -36.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 346K USD -78.3%
Liabilities 31.4M USD -40.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 140K USD
Retained Earnings (Accumulated Deficit) -389M USD -27.6%
Stockholders' Equity Attributable to Parent 175M USD -25%
Liabilities and Equity 206M USD -27.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 11.9M USD
Net Cash Provided by (Used in) Financing Activities 375K USD -9.2%
Net Cash Provided by (Used in) Investing Activities -20.3M USD -204%
Common Stock, Shares, Issued 42.5M shares +0.91%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.05M USD +78.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 276M USD -6.13%
Deferred Tax Assets, Valuation Allowance 112M USD +15%
Deferred Tax Assets, Gross 112M USD +15%
Operating Lease, Liability 3.41M USD -37.2%
Depreciation 501K USD +13.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -83.7M USD +13.9%
Lessee, Operating Lease, Liability, to be Paid 3.51M USD -38.3%
Property, Plant and Equipment, Gross 11.5M USD +20.2%
Operating Lease, Liability, Current 2.22M USD -4.97%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.02M USD -57.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.49M USD +6.32%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +97.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 102K USD -61.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 957K USD -61.6%
Deferred Tax Assets, Operating Loss Carryforwards 69.9M USD +66.4%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 613K USD +2.34%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 24.6M USD +3.18%